GLP-1 verhoogt vervolgens de insuline-afgifte door de alvleesklier, vertraagt de maaglediging (waardoor je langer vol blijft), en vergroot het verzadigingsgevoel in je hersenen
Semaglutide is a GLP-1 analogue suitable for once-weekly administration, and is in development for the treatment of T2D
With the right actives, you can effectively fade dark spots and bring out a healthy, radiant glow
Remember that Saxenda treatment involves weekly dose escalation to 3.0 mg daily, with treatment discontinued if at least 5% weight loss is not achieved after 12 weeks on the full dose
With the Medicines Amendment Bill streamlining approvals, the door is opening for repurposed therapies to enter the NZ pipeline faster
For patients with high cardiovascular risk, additional options include PCSK9 inhibitors and newer agents such as inclisiran (NICE TA733) and bempedoic acid (NICE TA694)